1. Ibrutinib‐associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma. (6th January 2015) Authors: Furtado, Michelle; Wang, Michael L.; Munneke, Brian; McGreivy, Jesse; Beaupre, Darrin M.; Rule, Simon Journal: British journal of haematology Issue: Volume 170:Number 1(2015:Jul.) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphoma. (16th March 2020) Authors: Fowler, Nathan H.; Nastoupil, Loretta; De Vos, Sven; Knapp, Mark; Flinn, Ian W.; Chen, Robert; Advani, Ranjana H.; Bhatia, Sumeet; Martin, Peter; Mena, Raul; Davis, Richard Eric; Neelapu, Sattva S.; Eckert, Karl; Ping, Jerry; Co, Melannie; Beaupre, Darrin M.; Neuenburg, Jutta K.; Palomba, M. Lia Journal: British journal of haematology Issue: Volume 189:Number 4(2020) Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗